Percutaneous ablation of hepatocellular carcinoma;Traitement percutané du carcinome hépatocellulaire

Gastroenterologie Clinique et Biologique

Volumn 27, Issue 4, 2003, Pages 381-390

  Sitruk, Véronique ^a,b   Seror, Olivier ^a   Grando Lemaire, Véronique ^a   Mohand, Djamila ^a   N'Kontchou, Gisèle ^a   Ganne Carrie, Nathalie ^a,b   Beaugrand, Michel ^a   Sellier, Nicolas ^a   Trinchet, Jean Claude ^a,b  

^a HÔPITAL JEAN VERDIER   (France)

^b UNIVERSITÉ PARIS 13   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ALCOHOL; GADOLINIUM; MITOXANTRONE; VASOCONSTRICTOR AGENT;

CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CHEMICAL PERCUTANEOUS ABLATION THERAPY; CRYOTHERAPY; DRUG RESPONSE; EVALUATION; HUMAN; LIVER CELL CARCINOMA; LOW LEVEL LASER THERAPY; RADIOFREQUENCY; REVIEW; SURVIVAL RATE; TECHNIQUE; THERMAL PERCUTANEOUS ABLATION THERAPY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR NECROSIS; TUMOR RECURRENCE; TUMOR VOLUME; CATHETER ABLATION; LIVER TUMOR; METHODOLOGY; PATIENT SELECTION; PROGNOSIS;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; HUMANS; LIVER NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; PROGNOSIS;

EID: 0037507085     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Ganne-Carrié N, Chevret S, Barbare JC, Chaffaud S, Grando V, Vogt AM, et al. Dépistage et traitement précoce du carcinome hépatocellulaire. Enquête concernant les intentions des hépatogastroentérologues en France. Gastroenterol Clin Biol 2002;26: 570-7.
2. Sherman M. Screening for hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 1999;13:623-35.
3. Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G, et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 2001;48:251-9.
4. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 2001;35:421-30.
5. Trinchet JC, Beaugrand M. Treatment of hepatocellular carcinoma in patients with cirrhosis. J Hepatol 1997;27:756-65.
6. Bruix J, Llovet JM. Locoregional treatments for hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 1999;13:611-22.
7. Leyendecker JR, Dodd GD, 3rd. Minimally invasive techniques for the treatment of liver tumors. Semin Liver Dis 2001;21:283-91.
8. Dick EA, Taylor-Robinson SD, Thomas HC, Gedroyc WM. Ablative therapy for liver tumours. Gut 2002;50:733-9.
9. Livraghi T, Giorgio A, Marin G, Salmi A, Desio I, Bolondi L, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995; 197:101-8.
10. Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radio-frequency energy. Radiology 2000;217:633-46.
11. Grasso A, Watkinson AF, Tibballs JM, Burroughs AK. Radiofrequency ablation in the treatment of hepatocellular carcinoma. A clinical viewpoint. J Hepatol 2000;33:667-72.
12. Ohnishi K, Yoshioka H, Ito S, Fujiwara K. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 1998:27:67-72.
13. Yoon HK, Song HY, Sung KB, Chung YH, Lee YS, Suh DJ, et al. Percutaneous hot saline injection therapy. Effectiveness in large hepatocellular carcinoma. J Vasc Intervent Radiol 1999;10:477-82.
14. Farres MT, De Baere T, Lagrange C, Ramirez L, Rougier P, Munck JN, et al. Percutaneous mitoxantrone injection for primary and secondary liver tumors: preliminary results. Cardiovasc Intervent Radiol 1998;21:399-403.
15. Lu DSK, Raman SS, Vodopich DJ, Wang M, Sayre J, Lassman C. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: Assessment of the « heat sink » effect. Am J Roentgenol 2002;178:47-51.
16. Rossi S, Garbagnati F, Lencioni R, Allgaier HP, Marchiano A, Fornari F, et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000;217:119-26.
17. Yamasaki T, Kurokawa F, Shirahashi H, Kusano N, Hironaka K, Okita K. Percutaneous radiofrequency ablation therapy with combined angiography and computed tomography assistance for patients with hepatocellular carcinoma. Cancer 2001;91:1342-8.
18. Goldberg SN, Hahn PF, Halpern EF, Fogle RM, Gazelle GS. Radio-frequency tissue ablation: effect of pharmacologic modulation of blood flow on coagulation diameter. Radiology 1998;209:761-7.
19. Wood BJ, Ramkaransingh JR, Fojo T, Walther MM, Libutti SK. Percutaneous tumor ablation with radiofrequency. Cancer 2002;94: 443-51.
20. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, et al. Hepatocellular carcinoma. Radio-frequency ablation of medium and large lesions. Radiology 2000;214:761-8.
21. Boehm T, Malich A, Goldberg SN, Reichenbach JR, Hilger I, Hauff P, et al. Radio-frequency tumor ablation: internally cooled electrode versus saline-enhanced technique in an aggressive rabbit tumor model. Radiology 2002;222:805-13.
22. Lu MD, Chen JW, Xie XY, Liu L, Huang XQ, Liang LJ, et al. Hepatocellular carcinoma: US-guided percutaneous microwave coagulation therapy. Radiology 2001;221:167-72.
23. Seki T, Wakabayashi M, Nakagawa T, Itho T, Shiro T, Kunieda K, et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994;74:817-25.
24. Sato M, Watanabe Y, Kashu Y, Nakata T, Hamada Y, Kawachi K. Sequential percutaneous microwave coagulation therapy for liver tumor. Am J Surg 1998;175:322-4.
25. Ishida T, Murakami T, Shibata T, Inoue Y, Takamura M, Niinobu T, et al. Percutaneous microwave tumor coagulation for hepatocellular carcinomas with interruption of segmental hepatic blood flow. J Vasc Interv Radiol 2002;13:185-91.
26. Yamasaki T, Kato A, Kurokawa F, Hironaka K, Kubo K, Yabusita Y, et al. Percutaneous hot water injection and microwave coagulation therapy for small hepatocellular carcinoma. Hepatol Res 1997;9:192-200.
27. Shibata T, Iimuro Y, Yamamoto Y, Maetani Y, Ametani F, Itoh K, et al. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 2002;223:331-7.
28. Pacella CM, Bizzarri G, Magnolfi F, Cecconi P, Caspani B, Anelli V, et al. Laser thermal ablation in the treatment of small hepatocellular carcinoma: results in 74 patients. Radiology 2001;221:712-20.
29. Vogl TJ, Eichler K, Straub R, Engelmann K, Zangos S, Woitaschek D, et al. Laser-induced thermotherapy of malignant liver tumors: general principals, equipment(s), procedure(s), side effects, complications and results. Eur J Ultrasound 2001;13:117-27.
30. Wong WS, Patel SC, Cruz FS, Gala KV, Turner AF. Cryosurgery as a treatment for advanced stage hepatocellular carcinoma: Results, complications, and alcohol ablation. Cancer 1998;82:1268-78.
31. Silverman SG, Tuncali K, Adams DF, vanSonnenberg E, Zou KH, Kacher DF, et al. MR imaging-guided percutaneous cryotherapy of liver tumors: initial experience. Radiology 2000;217:657-64.
32. Ohmoto K, Mimura N, Iguchi Y, Mitsui Y, Shimabara M, Kuboki M, et al. CT-guided percutaneous ethanol injection therapy for ultrasonically invisible hepatocellular carcinoma. Hepatogastroenterology 2002;49:297-9.
33. Shibata T, Iimuro Y, Yamamoto Y, Ikai I, Itoh K, Maetani Y, et al. CT-guided transthoracic percutaneous ethanol injection for hepatocellular carcinoma not detectable with US. Radiology 2002;223:115-20.
34. Shirato K, Morimoto M, Tomita N, Kokawa A, Sugimori K, Saito T, et al. Hepatocellular carcinoma: therapeutic experience with percutaneous ethanol injection under real-time contrast-enhanced color Doppler sonography with the contrast agent Levovist. J Ultrasound Med 2002;21:1015-22.
35. Lu DS, Sinha S, Lucas J, Farahani K, Lufkin R, Lewin K. MR-guided percutaneous ethanol ablation of liver tissue in a.2-T open MR system: preliminary study in porcine model. J Magn Reson Imaging 1997;7:303-8.
36. Quesson B, de Zwart JA, Moonen CT. Magnetic resonance temperature imaging for guidance of thermotherapy. J Magn Reson Imaging 2000;12:525-33.
37. Rossi S, Buscarini E, Garbagnati F, Distasi M, Quaretti P, Rago M, et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. Am J Roentgenol 1998;170:1015-22.
38. Cioni D, Lencioni R, Bartolozzi C. Percutaneous ablation of liver malignancies: imaging evaluation of treatment response. Eur J Ultrasound 2001;13:73-93.
39. Leyendecker JR, Dodd GD, 3rd, Halff GA, McCoy VA, Napier DH, Hubbard LG, et al. Sonographically observed echogenic response during intraoperative radiofrequency ablation of cirrhotic livers: pathologic correlation. AJR Am J Roentgenol 2002;178:1147-51.
40. Lim HK, Choi D, Lee WJ, Kim SH, Lee SJ, Jang HJ, et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation. Evaluation with follow-up multiphase helical CT. Radiology 2001;221:447-54.
41. Morimoto M, Sugimori K, Shirato K, Kokawa A, Tomita N, Saito T, et al. Treatment of hepatocellular carcinoma with radiofrequency ablation. Radiologic-histologic correlation during follow-up periods. Hepatology 2002;35:1467-75.
42. Fujita T, Honjo K, Ito K, Takano K, Koike S, Okazaki H, et al. Dynamic MR follow-up of small hepatocellular carcinoma after percutaneous ethanol injection therapy. J Comput Assist Tomogr 1998;22:379-86.
43. Sironi S, Livraghi T, Meloni F, Decobelli F, Ferrero CG, Delmaschio A. Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up. Am J Roentgenol 1999;173: 1225-9.
44. Lencioni R, Caramella D, Bartolozzi C. Response of hepatocellular carcinoma to percutaneous ethanol injection. CT and MR evaluation. J Comput Assist Tomogr 1993;17:723-9.
45. Dromain C, de Baere T, Elias D, Kuoch V, Ducreux M, Boige V, et al. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology 2002;223:255-62.
46. Choi D, Lim HK, Kim SH, Lee WJ, Jang HJ, Kim H, et al. Assessment of therapeutic response in hepatocellular carcinoma treated with percutaneous radio frequency ablation: comparison of multiphase helical computed tomography and power Doppler ultrasonography with a microbubble contrast agent. J Ultrasound Med 2002;21:391-401.
47. Cioni D, Lencioni R, Rossi S, Garbagnati F, Donati F, Crocetti L, et al. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome. Am J Roentgenol 2001;177:783-8.
48. Pompili M, Rapaccini GL, Covino M, Pignataro G, Caturelli E, Siena DA, et al. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy. Cancer 2001;92:126-35.
49. Sherman M. Alphafetoprotein: an obituary. J Hepatol 2001;34:603-5.
50. Shiina S, Tagawa K, Unuma T, Fujino H, Uta Y, Niwa Y, et al. Percutaneous ethanol injection therapy of hepatocellular carcinoma: analysis of 77 patients. Am J Roentgenol 1990;155:1221-6.
51. Castellano L, Calandra M, Blanco CD, Desio I. Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients. J Hepatol 1997;27:862-70.
52. Hasegawa S, Yamasaki N, Hiwaki T, Sako K, Komorizono Y, Baba Y, et al. Factors that predict intrahepatic recurrence of hepatocellular carcinoma in 81 patients initially treated by percutaneous ethanol injection. Cancer 1999;86:1682-90.
53. Koda M, Murawaki Y, Mitsuda A, Ohyama K, Horie Y, Suou T, et al. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma. Cancer 2000;88:529-37.
54. Lencioni R, Bartolozzi C, Carmella D, Paolicchi A, Carrai M, Maltinti G, et al. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients. Cancer 1995;76:1737-46.
55. Orlando A, Dantoni A, Camma C, Albanese M, Livraghi T, Torzilli G, et al. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. A validated prognostic model. Am J Gastroenterol 2000;95:2921-7.
56. Pompili M, Rapaccini GL, Deluca F, Caturelli E, Astone A, Siena DA, et al. Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection. Cancer 1997;79:1501-8.
57. Shiina S, Teratani T, Obi S, Hamamura K, Koike Y, Omata M. Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation. Oncology 2002;62: 64-8.
58. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma. Treatment with radio-frequency ablation versus ethanol injection. Radiology 1999;210:655-61.
59. Vilana R, Bruix J, Bru C, Ayuso C, Sole M, Rodes J. Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology 1992;16: 353-7.
60. Tanaka K, Nakamura S, Numata K, Kondo M, Morita K, Kitamura T, et al. The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis. Cancer 1998;82:78-85.
61. Meloni F, Lazzaroni S, Livraghi T. Percutaneous ethanol injection: single session treatment. Eur J Ultrasound 2001;13:107-15.
62. Giorgio A, Tarantino L, Mariniello N, de Stefano G, Perrotta A, Aloisio V, et al. Percutaneous ethanol injection under general anesthesia for hepatocellular carcinoma: 3 year survival in 112 patients. Eur J Ultrasound 1998;8:201-6.
63. Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK. Treatment of intrahepatic malignancy with radiofrequency ablation. Radiologic-pathologic correlation. Cancer 2000;88:2452-63.
64. Buscarini L, Buscarini E, Di Stasi M, Vallisa D, Quaretti P, Rocca A. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol 2001;11:914-21.
65. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Percutaneous ablative therapies for small hepatocellular carcinoma: radio-frequency or percutaneous ethanol injection? Response. Radiology 2000;216:305-6.
66. Rossi S, Distasi M, Buscarini E, Quaretti P, Garbagnati F, Squassante L, et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. Am J Roentgenol 1996;167:759-68.
67. Francica G, Marone G. Ultrasound-guided percutaneous treatment of hepatocellular carcinoma by radiofrequency hyperthermia with a 'cooled-tip needle'. A preliminary clinical experience. Eur J Ultrasound 1999;9:145-53.
68. Di Stasi M, Buscarini L, Livraghi T, Giorgio A, Salmi A, Desio I, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multicenter survey of evaluation practices and complication rates. Scand J Gastroenterol 1997;32:1168-73.
69. Ohmoto K, Kunieda T, Shibata N, Yamamoto S. Intraperitoneal hemorrhage as a major complication of percutaneous ethanol injection therapy for hepatocellular carcinoma. Hepatogastroenterology 2000;47:1199-202.
70. Hoshida Y, Shiratori Y, Koike Y, Obi S, Hamamura K, Teratani T, et al. Hepatic volumetry to predict adverse events in percutaneous ablation of hepatocellular carcinoma. Hepatogastroenterology 2002; 49:451-5.
71. Lencioni R, Cioni D, Uliana M, Bartolozzi C. Fatal thrombosis of the portal vein following single-session percutaneous ethanol injection therapy of hepatocellular carcinoma. Abdom Imaging 1998;23:608-10.
72. Seki S, Kitada T, Otogawa K, Yamada T, Sakaguchi H, Nakamura K. Gastric ulcer as a rare complication of percutaneous ethanol injection for hepatocellular carcinoma. Am J Gastroenterol 2002;97:770-1.
73. Seki T, Wakabayashi M, Nakagawa T, Imamura M, Tamai T, Nishimura A, et al. Hepatic infarction following percutaneous ethanol injection therapy for hepatocellular carcinoma. Eur J Gastroenterol Hepatol 1998;10:915-8.
74. Livraghi T, Benedini V, Lazzaroni S, Meloni F, Torzilli G, Vettori C. Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma. Cancer 1998;83:48-57.
75. Ishii H, Okada S, Okusaka T, Yoshimori M, Nakasuka H, Shimada K, et al. Needle tract implantation of hepatocellular carcinoma after percutaneous ethanol injection. Cancer 1998;82:1638-42.
76. Louha M, Poussin K, Ganne N, Zylberberg H, Nalpas B, Nicolet J, et al. Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer. Hepatology 1997;26:998-1005.
77. Llovet JM, Vilana R, Bru C, Bianchi L, Salmeron JM, Boix L, et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001;33: 1124-9.
78. Yamagami T, Nakamura T, Kato T, Matsushima S, Iida S, Nishimura T. Skin injury after radiofrequency ablation for hepatic cancer. Am J Roentgenol 2002;178:905-7.
79. Meloni MF, Goldberg SN, Moser V, Piazza G, Livraghi T. Colonic perforation and abscess following radiofrequency ablation treatment of hepatoma. Eur J Ultrasound 2002;15:73-6.
80. Bolondi L, Gaiani S, Celli N, Piscaglia F. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 2001;34:608.
81. De Sio I, Castellano L, De Girolamo V, Di Santolo SS, Marone A, Blanco CD, et al Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 2001;34:609-10.
82. Goldberg SN, Solbiati L. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 2001;34:609.
83. Livraghi T. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 2001;34:608-9.
84. Poon RTP, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000;232:10-24.
85. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002;31:339-46.
86. Khan KN, Yatsuhashi H, Yamasaki K, Yamasaki M, Inoue O, Koga M, ct al. Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection. J Hepatol 2000;32:269-78.
87. Sato S, Shiratori Y, Imamura M, Teratani T, Obi S, Koike Y, et al. Power Doppler signals after percutaneous ethanol injection therapy for hepatocellular carcinoma predict local recurrence of tumors: a prospective study using 199 consecutive patients. J Hepatol 2001;35:225-34.
88. Kumada T, Nakano S, Takeda I, Sugiyama K, Osada T, Kiriyama S, et al. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology 1997;25:87-92.
89. Izumi N, Asahina Y, Noguchi O, Uchihara M, Kanazawa N, Itakura J, et al. Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation. Cancer 2001;91:949-56.
90. Gournay J, Tchuenbou J, Richou C, Masliah C, Lerat F, Dupas B, et al. Percutaneous ethanol injection vs. resection in patients with small single hepatocellular carcinoma: a retrospective case-control study with cost analysis. Aliment Pharmacol Ther 2002;16:1529-38.
91. Livraghi T, Bolondi L, Buscarini L, Cottone M, Mazziotti A, Morabito A, et al. No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. J Hepatol 1995;22:522-6.
92. Yamamoto J, Okada S, Shimada K, Okusaka T, Yamasaki S, Ueno H, et al. Treatment strategy for small hepatocellular carcinoma. Comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology 2001;34:707-13.
93. Caturelli E. Percutaneous ablative therapies for small hepatocellular carcinoma: radio-frequency or percutaneous ethanol injection? Radiology 2000;216:304-5.
94. Llovet JM, Mas X, Aponte JJ, Fuster J, Navasa M, Christensen E, et al. Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. Gut 2002;50:123-8.
95. Dohmen K, Shirahama M, Shigematsu H, Miyamoto Y, Torii Y, Irie K, et al. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate. Hepatogastroenterology 2001;48:1409-15.
96. Kamada K, Kitamoto M, Aikata H, Kawakami Y, Kono H, Imamura M, et al. Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinoma. Am J Surg 2002;184:284.
97. Koda M, Murawaki Y, Mitsuda A, Oyama K, Okamoto K, Idobe Y, et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma. A randomized control study. Cancer 2001;92:1516-24.
98. Lin ZY, Wang JH, Hsieh MY, Yu ML, Chen SC, Chuang WL, et al. Percutaneous ethanol injection of the supplying artery to hepatocellular carcinoma that is not amenable to conventional treatment. Br J Radiol 2000;73:833-9.
99. Seror O, N'Kontchou G, Ganne-Carrié N, Grando V, Trinchet JC, Ajavon Y, et al. Alcoolisation par ponction directe de l'artère nourricière dans le carcinome hépatocellulaire: efficacité, tolérance et résultats à long terme (résumé). Gastroenterol Clin Biol 2002;26:761.
100. Hynynen K, Pomeroy O, Smith DN, Huber PE, McDannold NJ, Kettenbach J, et al. MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study. Radiology 2001;219:176-85.